Clinical and pathological characteristics of patients with Leucine‐rich repeat kinase‐2 mutations
- 15 January 2009
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 24 (1), 32-39
- https://doi.org/10.1002/mds.22096
Abstract
Mutations in LRRK2 are the single most common known cause of Parkinson's disease (PD). Two new PD patients with LRRK2 mutation were identified from a cohort with extensive postmortem assessment. One of these patients harbors the R793M mutation and presented with the typical clinical and pathological features of PD. A novel L1165P mutation was identified in a second patient. This patient had the classical and pathological features of PD, but additionally developed severe neuropsychological symptoms and dementia associated with abundant neurofibrillary tangles in the hippocampal formation; features consistent with a secondary diagnosis of tangle‐predominant dementia. α‐Synuclein‐containing pathological inclusions in these patients also were highly phosphorylated at Ser‐129, similar to other patients with idiopathic PD. These two PD patients also were characterized by the presence of occasional cytoplasmic TDP‐43 inclusions in the temporal cortex, a finding that was not observed in three other patients with the G2019S mutation in LRRK2. These findings extend the clinical and pathological features that may be associated with LRRK2 mutations. © 2008 Movement Disorder SocietyKeywords
Funding Information
- National Institute on Aging (AG09215, AG17586)
- National Institute of Neurological Disorders and Stroke (NS053488)
- The Ellison Medical Foundation (AG-NS-0331-06)
This publication has 46 references indexed in Scilit:
- Evaluation of LRRK2 G2019S penetranceNeurology, 2007
- Autosomal dominant parkinsonism associated with variable synuclein and tau pathologyNeurology, 2004
- Staging of brain pathology related to sporadic Parkinson’s diseaseNeurobiology of Aging, 2002
- Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseasesAnnals of Neurology, 2002
- α-Synuclein is phosphorylated in synucleinopathy lesionsNature Cell Biology, 2002
- Alpha-synuclein and neurodegenerative diseasesNature Reviews Neuroscience, 2001
- A panel of epitope-specific antibodies detects protein domains distributed throughout human ?-synuclein in lewy bodies of Parkinson's diseaseJournal of Neuroscience Research, 2000
- Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.1998
- Neuropathology of Parkinsonʼs DiseaseJournal of Neuropathology and Experimental Neurology, 1996
- The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method.Journal of Neurology, Neurosurgery & Psychiatry, 1991